This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovative Contributions of Subhendu Kumar Mohanty
Introduction
Subhendu Kumar Mohanty is a prominent inventor based in Bengaluru, India. He has made significant strides in the field of pharmaceutical inventions, particularly through his research and development efforts at Merck Sharp & Dohme Corporation. His work highlights the importance of innovation in the medical field, focusing on the treatment and prevention of various diseases.
Latest Patents
Mohanty holds a patent for "Pyrrolidine derived beta 3 adrenergic receptor agonists." This invention encompasses compounds of Formula (I), pharmaceutical compositions derived from these compounds, and methods for their use in the treatment or prevention of diseases affected by the activation of the β3-adrenoceptor. This patent reflects his dedication to advancing therapeutic options in pharmacology.
Career Highlights
Throughout his career, Subhendu has demonstrated a commitment to innovation within the pharmaceutical industry. His contributions at Merck Sharp & Dohme Corporation have positioned him as an influential figure in drug development, particularly in targeting adrenergic receptors for medical applications.
Collaborations
In his research endeavors, Mohanty has collaborated with esteemed colleagues such as Kenneth Jay Barr and Mark E. Scott. These collaborations have fostered an environment of innovation and have led to substantial advancements in their respective areas of expertise, further enhancing the potential impact of their work on public health.
Conclusion
In conclusion, Subhendu Kumar Mohanty exemplifies the spirit of innovation in the pharmaceutical industry. His singular patent and collaborative efforts at Merck Sharp & Dohme Corporation underline his commitment to enhancing therapeutic strategies, showcasing the pivotal role of inventors in advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
